Hetero and the Gates Foundation partner to expand HIV prevention access
Hetero, parent of Camber Pharmaceuticals, is a global leader in antiretroviral (ARV) therapy, supplying around 40% of worldwide HIV and AIDS medicines.
Hetero
Hetero, parent of Camber Pharmaceuticals, is a global leader in antiretroviral (ARV) therapy, supplying around 40% of worldwide HIV and AIDS medicines.